|
|
The immune response of Th17 cells in the cervical diseases with high-risk human papillomavirus infection |
XUE Jisen1, ZHU Hua1, ZHANG Shenghui2, LYU Jieqiang3, HU Yan1 |
1.Department of Gynecology, the First Affiliated Hospital of Wenzhou Medical University, Wenzhou, 325015; 2.Department of Hematology, the First Affiliated Hospital of Wenzhou Medical University, Wenzhou, 325015; 3.Department of Gynecology, the Second Affiliated Hospital of Wenzhou Medical University, Wenzhou, 325027 |
|
Cite this article: |
XUE Jisen,ZHU Hua,ZHANG Shenghui, et al. The immune response of Th17 cells in the cervical diseases with high-risk human papillomavirus infection[J]. JOURNAL OF WEZHOU MEDICAL UNIVERSITY, 2017, 47(7): 504-509.
|
|
Abstract Objective: To study the role of cellular immunity in patients of cervical cancer with high-risk human papillomavirus (HPV) infection mediated by Th17 cells and IL-17. Methods: The study groups included 28 cervical cancer patients, 29 CIN3 patients, 30 CIN2 patients, 26 CIN1 patients, 25 high-risk HPV infected healthy women and 30 patients with HPV negative. The percentage of Th17 cells in the peripheral blood was detected by flow cytometry. The concentration of IL-17 in serum was examined by ELISA. Results: During the disease progression of cervical lesions, the proportion of Th17 cells in the total CD4+ cells showed a gradually increased tendency compared with the controls. The proportions differed significantly among the study groups and the control group (P<0.05). During the disease progression of cervical lesions, levels of IL-17 in serum showed a gradually increased tendency and differed significantly among all groups (P<0.05), but comparisons between any two groups were no significant difference (P>0.05). Conclusion: This study indicates that the cellular immunoreaction mediated by Th17 cells and IL-17 may be related to the infection of high-risk HPV, which contributes to the disease progression of its associated cervical diseases.
|
Received: 29 October 2016
|
|
|
|
|
[1] FERLAY J, SOERJOMATARAM I, DIKSHIT R, et al. Cancer incidence and mortality worldwide: sources, methods and major patterns in GLOBOCAN 2012[J]. Int J Cancer, 2015, 136(5): E359-386.
[2] SCHIFFMAN M, CASTLE P E, JERONIMO J, et al. Human papillomavirus and cervical cancer[J]. Lancet, 2007, 370(9590): 890-907.
[3] STEENBERGEN R D, SNIJDERS P J, HEIDEMAN D A, et al. Clinical implications of (epi) genetic changes in HPV-induced cervical precancerous lesions[J]. Nat Rev Cancer,2014, 14(6): 395-405.
[4] HARRINGTON L E, HATTON R D, MANGAN P R, et al. Interleukin 17-producing CD4+ effector T cells develop via a lineage distinct from the T helper type 1 and 2 lineages[J].Nat Immunol, 2005, 6(11): 1123-1132.
[5] PARK H, LI Z, YANG X O, et al. A distinct lineage of CD4 T cells regulates tissue inflammation by producing interleukin 17[J]. Nat Immunol, 2005, 6(11): 1133-1141.
[6] WHIBLEY N, GAFFEN S L. Brothers in arms: Th17 and Treg responses in Candida albicans immunity[J]. PLoS Pat-hog, 2014, 10(12): e1004456.
[7] JHA R, SRIVASTAVA P, SALHAN S, et al. Spontaneous secretion of interleukin-17 and-22 by human cervical cells in Chlamydia trachomatis infection[J]. Microbes Infect, 2011, 13(2): 167-178.
[8] RATHORE J S, WANG Y. Protective role of Th17 cells in pulmonary infection[J]. Vaccine, 2016, 34(13): 1504-1514.
[9] FIALOVA A, PARTLOVA S, SOJKA L, et al. Dynamics of T-cell infiltration during the course of ovarian cancer: the gradual shift from a Th17 effector cell response to a predominant infiltration by regulatory T-cells[J]. Int J Cancer, 2013, 132(5): 1070-1079.
[10] YOSHIDA N, KINUGASA T, MIYOSHI H, et al. A high RORyT/CD3 ratio is a strong prognostic factor for postoperative survival in advanced colorectal cancer: analysis of helper T cell lymphocytes (Th1, Th2, Th17 and regulatory T cells)[J]. Ann Surg Oncol, 2016, 23(3): 919-927.
[11] MIN H K, KIM S M, BAEK S Y, et al. Anthocyanin extracted from black soybean seed coats prevents autoimmune arthritis by suppressing the development of Th17 cells and synthesis of proinflammatory cytokines by such cells, via inhibition of NF-κB[J]. PLoS One, 2015, 10(11): e0138201.
[12] YANG W, DING X, DENG J, et al. Interferon-gamma negatively regulates Th17-mediated immunopathology during mouse hepatitis virus infection[J]. J Mol Med (Berl), 2011, 89(4): 399-409.
[13] CHANG Q, WANG Y K, ZHAO Q, et al. Th17 cells are increased with severity of liver inflammation in patients with chronic hepatitis C[J]. J Gastroenterol Hepatol, 2012, 27(2): 273-278.
[14] SURYAWANSHI A, VEIGA-PARGA T, RAJASAGI N K, et al. Role of IL-17 and Th17 cells in herpes simplex virus-induced corneal immunopathology[J]. J Immunol, 2011, 187(4): 1919-1930.
[15] WANG J, LI F, WEI H, et al. Respiratory influenza virus infection induces intestinal immune injury via microbiota-mediated Th17 cell-dependent inflammation[J]. J Exp Med, 2014, 211(12): 2397-2410. |
|
|
|